Topical budesonide reduces esophageal stricture after endoscopic mucosal resection: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2020-12-29 12:30 GMT | Update On 2023-10-16 09:32 GMT

According to recent research, investigators have found that topical budesonide might be associated with a reduction of esophageal stricture after endoscopic mucosal resection or endoscopic submucosal dissection.

The study is published in the Journal of Gastrointestinal Endoscopy.

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are treatment modalities for Barrett's esophagus containing high-grade dysplasia or early cancer. Injectional corticosteroid therapy decreases the risk of procedure-related esophageal stricture (ES) formation.

Therefore, Michael J Bartel and associates from the Division of Gastroenterology and Hepatology, Mayo Clinic, Philadelphia, Pennsylvania carried out the present study to assess the efficacy of topical budesonide on the rate of ES formation after EMR or ESD.

The authors prospectively included patients from 3 tertiary endoscopy centers who received 3 mg budesonide orally twice a day for 8 weeks after esophageal EMR or ESD of 50% or more of the esophageal circumference. These patients were matched (1:3 ratio) with a retrospective, consecutive patient cohort who underwent EMR or ESD of 50% or more esophageal circumference without concomitant corticosteroid therapy. The primary endpoint was the presence of ES at a 12-week follow-up. Twenty-five patients (budesonide) were matched with 75 patients (no budesonide). Most underwent EMR for Barrett's esophagus with biopsy-proven high-grade dysplasia or suspected T1a cancer.

The following results were highlighted-

a. Although most baseline characteristics did not differ significantly, patients in the budesonide cohort tended to have a higher proportion of circumferential EMR.

b. The proportion of patients with ES was not significantly lower in the budesonide cohort (16% vs 28%).

c. In logistic regression analysis, budesonide remained associated with lower incidence of ES (P = .023); however, when controlling baseline characteristics with a propensity score-weighted logistic regression model, there was no significant effect on ES formation (P = .176).

Hence, the authors concluded that "topical budesonide might be associated with a reduction of ES after EMR or ESD; however, further studies are needed to verify the results."

Article Source : Journal of Gastrointestinal Endoscopy

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Topical budesonide reduces esophageal stricture after endoscopic mucosal resection: Study

Similar News

Single-Incision Laparoscopic Cholecystectomy Safe, Feasible, and Comparable to CLC: Study Shows

Peptic ulcer does not significantly increase CVD risk, finds study

Preemptive Genetic Testing Feasible for Reducing Chemotherapy Toxicity in GI Cancer, Finds Trial

Multifactorial Risk Control Lowers Liver Disease Burden in Type 2 Diabetes, Study Shows

AI analysis of colonoscopy improves assessment of Crohn's disease: Study

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research

Elevated CAR on POD3 Predicts Prolonged Hospital Stay After Advanced hepatobiliary or pancreatic surgery: Study

Smartphone Use on Toilet Linked to Higher Hemorrhoid Risk: Study